MK-7655A

MK-7655A · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7655A, covering 2021-12-13 to 2021-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) [Phase 1]

See pricing